Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $639.22 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $325.90 | 5 | $0 (2021) |
| Medtronic Vascular, Inc. | $139.12 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $132.82 | 6 | $0 (2023) |
| PFIZER INC. | $41.38 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $54.78 | 2 | E.R. Squibb & Sons, L.L.C. ($54.78) |
| 2022 | $17.23 | 1 | E.R. Squibb & Sons, L.L.C. ($17.23) |
| 2021 | $66.04 | 3 | E.R. Squibb & Sons, L.L.C. ($48.30) |
| 2020 | $308.16 | 4 | Janssen Pharmaceuticals, Inc ($308.16) |
| 2019 | $139.12 | 1 | Medtronic Vascular, Inc. ($139.12) |
| 2018 | $32.33 | 2 | PFIZER INC. ($19.82) |
| 2017 | $21.56 | 1 | PFIZER INC. ($21.56) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/12/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.06 | General |
| Category: Cardiovascular | ||||||
| 03/06/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $30.72 | General |
| 12/20/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Cardiovascular | ||||||
| 05/20/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.61 | General |
| Category: Cardiovascular | ||||||
| 03/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/19/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.69 | General |
| Category: Cardiovascular | ||||||
| 04/09/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/25/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/04/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $130.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/29/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/24/2019 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $139.12 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 08/24/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.51 | General |
| Category: Cardiovascular | ||||||
| 02/07/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 291 | 484 | $147,527 | $45,792 |
| 2022 | 4 | 173 | 390 | $104,606 | $31,564 |
| 2021 | 4 | 339 | 840 | $343,514 | $79,913 |
| 2020 | 4 | 387 | 754 | $310,220 | $73,544 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 92 | 197 | $63,113 | $19,353 | 30.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 73 | 159 | $32,196 | $10,852 | 33.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 62 | 64 | $32,736 | $9,365 | 28.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 64 | 64 | $19,482 | $6,223 | 31.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 82 | 264 | $69,960 | $21,200 | 30.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 27 | $13,878 | $4,195 | 30.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 70 | $12,880 | $3,709 | 28.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 29 | 29 | $7,888 | $2,460 | 31.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 145 | 521 | $206,070 | $48,130 | 23.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 79 | 80 | $63,428 | $14,382 | 22.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 58 | 179 | $49,408 | $11,599 | 23.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 57 | 60 | $24,608 | $5,803 | 23.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 118 | 325 | $133,250 | $31,206 | 23.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 93 | 97 | $70,800 | $17,649 | 24.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 94 | 248 | $74,400 | $16,591 | 22.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 82 | 84 | $31,770 | $8,099 | 25.5% |
About Dr. Amita Buddhdev, M.D
Dr. Amita Buddhdev, M.D is a Hospitalist healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2013. The National Provider Identifier (NPI) number assigned to this provider is 1649512237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amita Buddhdev, M.D has received a total of $639.22 in payments from pharmaceutical and medical device companies, with $54.78 received in 2023. These payments were reported across 14 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($639.22).
As a Medicare-enrolled provider, Buddhdev has provided services to 1,190 Medicare beneficiaries, totaling 2,468 services with total Medicare billing of $230,814. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Hospitalist
- Location Seattle, WA
- Active Since 03/21/2013
- Last Updated 05/18/2023
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1649512237
Products in Payments
- XARELTO (Drug) $325.90
- Reveal LINQ (Device) $139.12
- ELIQUIS (Drug) $119.42
- CAMZYOS (Drug) $24.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Seattle
Amrit Lamba, Md, MD
Hospitalist — Payments: $1,297
Binish Qureshi, Md, MD
Hospitalist — Payments: $628.30
George Lau, Md, MD
Hospitalist — Payments: $477.66
Dr. Rasa Izadnegahdar, M.d, M.D
Hospitalist — Payments: $469.11
Bushra Abid, Md, MD
Hospitalist — Payments: $364.12
Ronald Huang, Md, MD
Hospitalist — Payments: $328.43